Egyptian Pharmaceutical Market Research
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
-
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR
-
Ribo Biologics announced that the world's first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
-
Focusing on hearing and balanced medicine, why did Shurui Medical break into the 10 billion market of digital therapeutics?
Recommend Reading
-
Vietnam Drives ASEAN Towards a Modern Economy
-
Hormuz Reopening Signal: 155 Tankers Still Waiting
-
Qatar LNG Hit by Attack: 17% Export Capacity Lost, $20 Billion Wiped Out
-
USDA Puts Fresh Money Into Local Food Markets
-
Fertilizer Shock Reshapes Rice Export Decisions
-
This week, the ethyl acetate market in China has shown a strong performance
-
Premium Global Chemical Sourcing Requests (8-10Jun, 2026)
-
Port inventory rises, November ethylene glycol price center shifts downward
-
November Cyclohexane Market Demand Insufficient, Prices Remain Stable
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens